Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank De Wolf

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Journal of the Royal Society, Interface|June 10, 2016
Understanding the within-host dynamics of influenza A virus: from theory to clinical implicationsChristoforos Hadjichrysanthou, Emilie Cauët, Emma Lawrence, et al.
AIDS (London, England)|June 29, 2012
Could better tolerated HIV drug regimens improve patient outcome?Mikaela Smit, Colette Smit, Ide Cremin, et al.
The Open AIDS Journal|July 27, 2010
Measuring the Quality of Data Collection in a Large Observational Cohort of HIV and AIDSMariska Hillebregt, Elly de Lange-de Klerk, Dirk Knol, et al.
AIDS (London, England)|May 15, 2010
Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individualsArd I van Sighem, Luuk A J Gras, Peter Reiss, et al.
European Journal of Epidemiology|October 27, 2017
Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer's diseaseAlison K Ower, Christoforos Hadjichrysanthou, Luuk Gras, et al.
Mathematical Biosciences|November 26, 2009
Superinfection with a heterologous HIV strain per se does not lead to faster progressionIsaac Chun-Hai Fung, Manoj Gambhir, Ard van Sighem, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 24, 2012
The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: are we ready to infer poor adherence?Isaac C H Fung, Manoj Gambhir, Ard van Sighem, et al.
AIDS Research and Human Retroviruses|August 10, 2013
Loss to follow-up and mortality rates in HIV-1-infected patients in Curaçao before and after the start of combination antiretroviral therapyHillegonda Hermanides, Rebecca Holman, Luuk Gras, et al.
European Journal of Epidemiology|March 25, 2018
The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer's disease treatment?Stephanie Evans, Kevin McRae-McKee, Mei Mei Wong, et al.
Plos One|October 8, 2013
Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The NetherlandsMikaela Smit, Colette Smit, Suzanne Geerlings, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Journal of the Royal Society, Interface|June 10, 2016
Understanding the within-host dynamics of influenza A virus: from theory to clinical implicationsChristoforos Hadjichrysanthou, Emilie Cauët, Emma Lawrence, et al.
AIDS (London, England)|June 29, 2012
Could better tolerated HIV drug regimens improve patient outcome?Mikaela Smit, Colette Smit, Ide Cremin, et al.
The Open AIDS Journal|July 27, 2010
Measuring the Quality of Data Collection in a Large Observational Cohort of HIV and AIDSMariska Hillebregt, Elly de Lange-de Klerk, Dirk Knol, et al.
AIDS (London, England)|May 15, 2010
Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individualsArd I van Sighem, Luuk A J Gras, Peter Reiss, et al.
European Journal of Epidemiology|October 27, 2017
Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer's diseaseAlison K Ower, Christoforos Hadjichrysanthou, Luuk Gras, et al.
Mathematical Biosciences|November 26, 2009
Superinfection with a heterologous HIV strain per se does not lead to faster progressionIsaac Chun-Hai Fung, Manoj Gambhir, Ard van Sighem, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 24, 2012
The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: are we ready to infer poor adherence?Isaac C H Fung, Manoj Gambhir, Ard van Sighem, et al.
AIDS Research and Human Retroviruses|August 10, 2013
Loss to follow-up and mortality rates in HIV-1-infected patients in Curaçao before and after the start of combination antiretroviral therapyHillegonda Hermanides, Rebecca Holman, Luuk Gras, et al.
European Journal of Epidemiology|March 25, 2018
The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer's disease treatment?Stephanie Evans, Kevin McRae-McKee, Mei Mei Wong, et al.
Plos One|October 8, 2013
Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The NetherlandsMikaela Smit, Colette Smit, Suzanne Geerlings, et al.
Pageof 11